超广角成像上以周边为主的病变与糖尿病视网膜病变随时间恶化的风险的相关性
这项前瞻性多中心纵向观察性队列研究纳入388名参与者共544只非增殖性糖尿病视网膜病变眼,评估超广角成像上以周边为主的病变(PPL)与4年内疾病恶化的关联。结果显示彩色PPL与恶化无显著关联,而荧光素眼底血管造影(FA)PPL与恶化风险升高相关,独立于基线糖尿病视网膜病变严重程度量表(DRSS)评分。
要点
- FA PPL阳性眼4年恶化率50%,阴性眼31%,HR 1.72(95%CI 1.25-2.36,P<.001)。
- 彩色PPL与疾病恶化无显著关联(HR 0.78,95%CI 0.57-1.08,P=.13)。
- FA PPL与恶化风险的关联独立于基线DRSS评分。
核心结论
- 彩色PPL与疾病恶化无显著关联,而FA PPL阳性与4年内更高的疾病恶化风险相关,且独立于基线DRSS评分。
- 作者认为使用超广角FA评估标准ETDRS视野以外的视网膜可能提高预测非增殖性糖尿病视网膜病变眼疾病恶化的能力。
- 作者认为这些发现支持将超广角FA用于未来的糖尿病视网膜病变分期系统和临床诊疗,以更准确判断非增殖性糖尿病视网膜病变眼的预后。
研究设计与样本
- 前瞻性、多中心、纵向观察性队列研究,在美国和加拿大37个中心开展,2015年2月至12月入组388名参与者。
- 基线和每年至第4年获取200°超广角彩色图像,在阅读中心进行DRSS分级;基线超广角彩色和超广角荧光素眼底血管造影(FA)图像评估PPL。
- 数据分析时间为2020年5月至2022年6月;糖尿病视网膜病变或糖尿病黄斑水肿的治疗由研究者自行决定。
- 分析纳入544只非增殖性糖尿病视网膜病变眼(182名[50%]女性参与者;中位年龄62岁;68%为白人)。
主要发现
- 4年疾病恶化率:基线轻度非增殖性糖尿病视网膜病变眼为45%,中度非增殖性糖尿病视网膜病变眼为40%,中重度非增殖性糖尿病视网膜病变眼为26%,重度非增殖性糖尿病视网膜病变眼为43%。
- 疾病恶化与基线彩色PPL无显著关联(有 vs 无:38% vs 43%;HR 0.78;95%CI 0.57-1.08;P=.13)。
- 疾病恶化与基线FA PPL相关(有 vs 无:50% vs 31%;HR 1.72;95%CI 1.25-2.36;P<.001)。
关键数值与推荐
- PPL定义为糖尿病视网膜病变病变在7个标准ETDRS视野外的范围大于视野内。
- 主要结局为疾病恶化,定义为DRSS恶化2步或以上或接受糖尿病视网膜病变治疗。
- 分析校正基线DRSS评分和同一参与者2只研究眼之间的相关性。
临床怎么用
- 作者认为使用超广角FA评估标准ETDRS视野以外的视网膜可能提高预测非增殖性糖尿病视网膜病变眼疾病恶化的能力。
- 作者认为这些发现支持将超广角FA用于未来的糖尿病视网膜病变分期系统和临床诊疗,以更准确判断非增殖性糖尿病视网膜病变眼的预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Ultra-widefield (UWF) imaging improves the ability to identify peripheral diabetic retinopathy (DR) lesions compared with standard imaging. Whether detection of predominantly peripheral lesions (PPLs) better predicts rates of disease worsening over time is unknown. OBJECTIVE: To determine whether PPLs identified on UWF imaging are associated with increased disease worsening beyond the risk associated with baseline Early Treatment Diabetic Retinopathy Study (ETDRS) Diabetic Retinopathy Severity Scale (DRSS) score. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a prospective, multicenter, longitudinal observational study conducted at 37 US and Canadian sites with 388 participants enrolled between February and December 2015. At baseline and annually through 4 years, 200° UWF-color images were obtained and graded for DRSS at a reading center. Baseline UWF-color and UWF-fluorescein angiography (FA) images were evaluated for the presence of PPL. Data were analyzed from May 2020 to June 2022. INTERVENTIONS: Treatment of DR or diabetic macular edema was at investigator discretion. MAIN OUTCOMES AND MEASURES: Predominantly peripheral lesions were defined as DR lesions with a greater extent outside vs inside the 7 standard ETDRS fields. Primary outcome was disease worsening defined as worsening 2 steps or more on the DRSS or receipt of DR treatment. Analyses were adjusted for baseline DRSS score and correlation between 2 study eyes of the same participant. RESULTS: Data for 544 study eyes with nonproliferative DR (NPDR) were analyzed (182 [50%] female participants; median age, 62 years; 68% White). The 4-year disease worsening rates were 45% for eyes with baseline mild NPDR, 40% for moderate NPDR, 26% for moderately severe NPDR, and 43% for severe NPDR. Disease worsening was not associated with color PPL at baseline (present vs absent: 38% vs 43%; HR, 0.78; 95% CI, 0.57-1.08; P = .13) but was associated with FA PPL at baseline (present vs absent: 50% vs 31%; HR, 1.72; 95% CI, 1.25-2.36; P < .001). CONCLUSIONS AND RELEVANCE: Although no association was identified with color PPL, presence of FA PPL was associated with greater risk of disease worsening over 4 years, independent of baseline DRSS score. These results suggest that use of UWF-FA to evaluate retinas peripheral to standard ETDRS fields may improve the ability to predict disease worsening in NPDR eyes. These findings support use of UWF-FA for future DR staging systems and clinical care to more accurately determine prognosis in NPDR eyes.
引用
- Marcus DM, Silva PS, Liu D, et al. Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time. JAMA Ophthalmol. 2022. PMID: 35980608. doi:10.1001/jamaophthalmol.2022.3131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。